×
Join our live online event
How top hedge funds use news to make money
form the stock market & how ordinary people are
copying their strategies
Register now!
form the stock market & how ordinary people are
copying their strategies
No thanks
TNXP – tonix pharmaceuticals holding corp. (US:NASDAQ)
DELAYED
$
| Volume Shares | |
| 1 Day Range | |
| Volume Ratio | |
| 52 Week High | |
| 52 Week Low |
| VWAP | |
| Today’s Volatility | |
| 20 Days Volatility | |
| Open | |
| Prior Close |
1D
5D
1M
3M
YTD
1Y
3Y
1 Day
TNXP
SPY
QQQ
Swipe to see more
Main News & Impact Reports
Date
Time
Symbol
Headline
Impact
3/31
12:31 pm
tnxp
InvestorNewsBreaks – Tonix Pharmaceuticals Holding Corp. (NASDAQ: TNXP) Reports Phase 1 Data for Lyme Disease Candidate TNX-4800, Plans Phase 2 Study [TheStreet.com]
Medium
Report
InvestorNewsBreaks – Tonix Pharmaceuticals Holding Corp. (NASDAQ: TNXP) Reports Phase 1 Data for Lyme Disease Candidate TNX-4800, Plans Phase 2 Study [TheStreet.com]
3/31
07:20 am
tnxp
Tonix Pharmaceuticals Announces Presentation of Phase 1 Data and Outlines Planned Adaptive Phase 2 Field Study of TNX-4800 for the Prevention of Lyme Disease, at the World Vaccine Congress Washington 2026 [Yahoo! Finance]
High
Report
Tonix Pharmaceuticals Announces Presentation of Phase 1 Data and Outlines Planned Adaptive Phase 2 Field Study of TNX-4800 for the Prevention of Lyme Disease, at the World Vaccine Congress Washington 2026 [Yahoo! Finance]
3/31
07:00 am
tnxp
Tonix Pharmaceuticals Announces Presentation of Phase 1 Data and Outlines Planned Adaptive Phase 2 Field Study of TNX-4800 for the Prevention of Lyme Disease, at the World Vaccine Congress Washington 2026
Medium
Report
Tonix Pharmaceuticals Announces Presentation of Phase 1 Data and Outlines Planned Adaptive Phase 2 Field Study of TNX-4800 for the Prevention of Lyme Disease, at the World Vaccine Congress Washington 2026
3/30
07:02 am
tnxp
Wall Street Breakfast Podcast: Mistral Loads Up On Nvidia [Seeking Alpha]
Medium
Report
Wall Street Breakfast Podcast: Mistral Loads Up On Nvidia [Seeking Alpha]
3/28
01:05 am
tnxp
Tonix Pharmaceuticals (TNXP) was downgraded by Wall Street Zen from "
Medium
Report
Tonix Pharmaceuticals (TNXP) was downgraded by Wall Street Zen from "
3/26
07:00 am
tnxp
Tonix Pharmaceuticals Announces First Participant Dosed in Phase 1 Investigator-Initiated Pharmacodynamic Study of TNX-1900 (Intranasal Potentiated Oxytocin) to Assess Potential for Treating Migraine and Craniofacial Pain
Medium
Report
Tonix Pharmaceuticals Announces First Participant Dosed in Phase 1 Investigator-Initiated Pharmacodynamic Study of TNX-1900 (Intranasal Potentiated Oxytocin) to Assess Potential for Treating Migraine and Craniofacial Pain
3/23
05:09 pm
tnxp
Tonix Pharmaceuticals Announces Presentations at World Vaccine Congress Washington 2026 [Yahoo! Finance]
Medium
Report
Tonix Pharmaceuticals Announces Presentations at World Vaccine Congress Washington 2026 [Yahoo! Finance]
3/23
04:32 pm
tnxp
Tonix Pharmaceuticals Announces Presentations at World Vaccine Congress Washington 2026
Medium
Report
Tonix Pharmaceuticals Announces Presentations at World Vaccine Congress Washington 2026
Date
Time
Symbol
Company Name
Action
%Chg
3/12/2026
05:30 pm
tnxp
tonix pharmaceuticals holding corp.
MISS
Report
-0.4%
tonix pharmaceuticals holding corp.
11/10/2025
04:15 pm
tnxp
tonix pharmaceuticals holding corp.
IN-LINE
Report
4.7%
tonix pharmaceuticals holding corp.
8/11/2025
04:15 pm
tnxp
tonix pharmaceuticals holding corp.
MISS
Report
1.3%
tonix pharmaceuticals holding corp.
5/12/2025
04:30 pm
tnxp
tonix pharmaceuticals holding corp.
BEAT
Report
5.8%
tonix pharmaceuticals holding corp.
Date
Time
Action
From
To
Firm
Impact
%Chg
Date
Time
Symbol
Headline
Impact
4/1
09:31 am
tnxp
Form 4 Tonix Pharmaceuticals For: Mar 31 Filed by: LEDERMAN SETH
Medium
Report
Form 4 Tonix Pharmaceuticals For: Mar 31 Filed by: LEDERMAN SETH
3/31
07:06 am
tnxp
Form 8-K Tonix Pharmaceuticals For: Mar 30
High
Report
Form 8-K Tonix Pharmaceuticals For: Mar 30
3/30
08:01 am
tnxp
Form DEF 14A Tonix Pharmaceuticals For: May 07
Medium
Report
Form DEF 14A Tonix Pharmaceuticals For: May 07
3/27
01:32 pm
tnxp
Form SCHEDULE 13G/A Tonix Pharmaceuticals Filed by: VANGUARD GROUP INC
Low
Report
Form SCHEDULE 13G/A Tonix Pharmaceuticals Filed by: VANGUARD GROUP INC
3/26
07:00 am
tnxp
Form 8-K Tonix Pharmaceuticals For: Mar 26
Medium
Report
Form 8-K Tonix Pharmaceuticals For: Mar 26
3/20
05:13 pm
tnxp
Form PRE 14A Tonix Pharmaceuticals For: May 07
Medium
Report
Form PRE 14A Tonix Pharmaceuticals For: May 07
3/18
05:04 pm
tnxp
Form 4 Tonix Pharmaceuticals For: Mar 18 Filed by: LEDERMAN SETH
High
Report
Form 4 Tonix Pharmaceuticals For: Mar 18 Filed by: LEDERMAN SETH
3/18
06:03 am
tnxp
Form 8-K Tonix Pharmaceuticals For: Mar 16
Medium
Report
Form 8-K Tonix Pharmaceuticals For: Mar 16
Stock Stats
| News Stats | |
|---|---|
| All News | |
| News Wires | |
| Media Monitoring | |
| SEC Edgar Filings | |
| Upgrades | |
| Downgrades | |
| Initiated | |
| Reiterated | |
| Last Earnings | |
| Last Earnings EPS | |
| Next Earnings | |
| Order Stats |
|---|
| Sub-Penny |
|
|
| Odd lot |
|
|
| Avg. bid-ask spread |
|
|
| Avg. bid-ask size |
|
|
| Shares at ask/bid |
|
|
| Off exchange |
|
|
Main News & Impact Reports
TOP News Gainers
2/26
Tonix Pharmaceuticals Announces Research Collaboration with Southern Research to Develop a Potential Vaccine to Protect Against New Coronavirus Disease 2019 (COVID-19) Based on Horsepox Virus (TNX-1800)
80.0%
3/20 Form 8-K Tonix Pharmaceuticals For: Mar 19 70.2%
12/11 Tonix Pharmaceuticals Announces New European Patent for the Composition and Formulation of TNX-102 SL 22.2%
9/5 Tonix Pharmaceuticals Holding Corp (NASDAQ: TNXP) was upgraded by analysts at ValuEngine from a "sell" rating to a "hold" rating. 19.7%
2/4 Tonix Pharmaceuticals to Participate in Upcoming February Investor Conferences 18.1%
5/21 Tonix Pharmaceuticals Will Present Results from Pharmacokinetic Analyses of TNX-102 SL in a Poster Presentation at the American Society of Clinical Psychopharmacology 16.0%
11/15 Tonix Pharmaceuticals Prices $9.0 Million Public Offering 15.4%
2/28 Form 424B5 Tonix Pharmaceuticals 15.3%
3/23 Tonix Pharmaceuticals to Deliver Virtual Presentation for Spring Investor Summit 15.1%
1/24 Tonix Pharmaceuticals Announces Successful Completion of a Fed-Fasting and Dose Proportionality Study of TNX-102 SL 14.8%
3/20 Form 8-K Tonix Pharmaceuticals For: Mar 19 70.2%
12/11 Tonix Pharmaceuticals Announces New European Patent for the Composition and Formulation of TNX-102 SL 22.2%
9/5 Tonix Pharmaceuticals Holding Corp (NASDAQ: TNXP) was upgraded by analysts at ValuEngine from a "sell" rating to a "hold" rating. 19.7%
2/4 Tonix Pharmaceuticals to Participate in Upcoming February Investor Conferences 18.1%
5/21 Tonix Pharmaceuticals Will Present Results from Pharmacokinetic Analyses of TNX-102 SL in a Poster Presentation at the American Society of Clinical Psychopharmacology 16.0%
11/15 Tonix Pharmaceuticals Prices $9.0 Million Public Offering 15.4%
2/28 Form 424B5 Tonix Pharmaceuticals 15.3%
3/23 Tonix Pharmaceuticals to Deliver Virtual Presentation for Spring Investor Summit 15.1%
1/24 Tonix Pharmaceuticals Announces Successful Completion of a Fed-Fasting and Dose Proportionality Study of TNX-102 SL 14.8%
TOP News Decliners
2/5
Tonix Pharmaceuticals Announces Outcome of Interim Analysis for Phase 3 RECOVERY Study of Tonmya® (TNX-102 SL) in PTSD
-48.5%
2/7 Form EFFECT Tonix Pharmaceuticals -39.5%
2/27 Form 4 Tonix Pharmaceuticals For: Feb 25 Filed by: MORRIS JESSICA EDGAR -37.6%
11/4 Form 8-K Tonix Pharmaceuticals For: Nov 04 -31.9%
3/24 Form 8-K Tonix Pharmaceuticals For: Mar 24 -26.0%
11/15 Form EFFECT Tonix Pharmaceuticals -25.0%
11/20 Tonix Pharma up 12% after hours on advancement of TNX-102 SL in AUD [Seeking Alpha] -22.7%
1/7 Tonix Pharmaceuticals to Present at Biotech Showcase 2020 -20.5%
7/15 Form S-1/A Tonix Pharmaceuticals -19.3%
11/25 Tonix Pharmaceuticals to Participate in Benchmark’s Annual Discovery 1x1 Conference -18.6%
2/7 Form EFFECT Tonix Pharmaceuticals -39.5%
2/27 Form 4 Tonix Pharmaceuticals For: Feb 25 Filed by: MORRIS JESSICA EDGAR -37.6%
11/4 Form 8-K Tonix Pharmaceuticals For: Nov 04 -31.9%
3/24 Form 8-K Tonix Pharmaceuticals For: Mar 24 -26.0%
11/15 Form EFFECT Tonix Pharmaceuticals -25.0%
11/20 Tonix Pharma up 12% after hours on advancement of TNX-102 SL in AUD [Seeking Alpha] -22.7%
1/7 Tonix Pharmaceuticals to Present at Biotech Showcase 2020 -20.5%
7/15 Form S-1/A Tonix Pharmaceuticals -19.3%
11/25 Tonix Pharmaceuticals to Participate in Benchmark’s Annual Discovery 1x1 Conference -18.6%
Don’t Miss Out On The Next BIG Stock Move
Never get left behind with our daily ‘Shakers & Movers’ newsletter. Discover the biggest gainer or loser in the stock market, and learn exactly WHY it moved. To find out which one caught Wall Street by surprise TODAY, sign up to our newsletter below: